Smart nursing cuts kidney damage risk in liver cancer patients
NCT ID NCT07681817
First seen Jul 02, 2026 · Last updated Jul 02, 2026
Summary
This study tests whether a personalized nursing program can prevent acute kidney injury (AKI) in people with liver cancer who undergo interventional therapy. Researchers first use a prediction model to classify patients into low, moderate, or high risk for AKI. Then, they provide targeted nursing care—like hydration support and medication management—based on each patient's risk level. The goal is to see if this proactive approach lowers AKI rates compared to standard care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
risk-stratified proactive nursing intervention
What this could lead to
If successful, this approach could reduce kidney injury after liver cancer procedures and improve patient recovery.
What could go wrong
This is a single-center study with 200 participants, so results may not apply broadly. The intervention is behavioral, not a drug, so effects may be modest.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER CANCER, ADULT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- PBV Imaging & Nitroglycerin in Liver Cancer NCT07682454
- Time-Restricted Eating for Liver Cancer Study (NCT06824974)
- Liver Function SPECT After Radiotherapy | NCT02967848
- RASEREM: Y-90 Resin Microspheres for Liver Cance NCT07345247
- FAD-Guided Therapy for Liver Cancer Trial NCT07314372
- Radioembolization & Angiotensin II for Liver Can NCT07312292
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••